Continually Updated Clinical Reference
 
 
  All Sources     eMedicine     Medscape     Drug Reference     MEDLINE
 
eMedicine - Human Bites : Article by

Quick Find
Authors & Editors
Introduction
Clinical
Differentials
Workup
Treatment
Medication
Follow-up
Miscellaneous
References

Related Articles
Child Abuse & Neglect: Physical Abuse




Patient Education
Bites and Stings Center

Human Bites Overview

Human Bites Causes

Human Bites Symptoms

Human Bites Treatment




Author: Clifford Spanierman, MD, Consulting Staff, Departments of Emergency Medicine and Pediatrics, Lutheran General Hospital of Oak Brook, Advocate Health System

Editors: Harold K Simon, MD, Director of Fellowship and Research, Associate Professor, Department of Pediatrics, Division of Pediatric Emergency Medicine, Emory University School of Medicine; Mary L Windle, PharmD, Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy, Pharmacy Editor, eMedicine.com, Inc; Wayne Wolfram, MD, MPH, Clinical Associate Professor, Departments of Pediatrics, Children's Hospital and University of Cincinnati; Paul D Petry, DO, FACOP, FAAP, Clinical Assistant Professor of Pediatrics, University of North Dakota, School of Medicine and Health Sciences; Consulting Staff, Altru Health System; Russell W Steele, MD, Professor and Vice Chairman, Department of Pediatrics, Head, Division of Infectious Diseases, Louisiana State University Health Sciences Center

Author and Editor Disclosure

Synonyms and related keywords: human bites, puncture wound, hand infection, wound infection, Staphylococcus, Streptococcus, Clostridium, fight wound, laceration, osteomyelitis, closed-fist bite wounds

Background

Human bites are common in the pediatric age group. Bites may be inflicted during altercations, during play, or even by abusive adults. Bite wounds vary from superficial abrasions to severely disfiguring injuries. The most common complication of human bites is infection. Many concerned parents bring children (particularly younger children) with superficial bite wounds to medical personnel because of the fear of infectious disease transmission.

Pathophysiology

Bacteria heavily colonize the human mouth. Oral flora contains many potentially pathogenic aerobic and anaerobic bacteria. Among these bacteria are Staphylococcus, Streptococcus, Clostridium, and fusiform-shaped species. Bite wounds can inoculate the affected tissue with these microorganisms.

Bites cause varying amounts of tissue destruction. Tissue destruction from human bites tends to be less severe than that of dog bites. Nevertheless, human bites may be potentially disabling or life threatening.

Frequency

United States

Estimates vary regarding the frequency of human bites evaluated in US emergency departments (EDs). Some sources report an annual incidence of 250,000 human bites. This is well below the incidence of dog bites and is approximately half the incidence of cat bites.

Mortality/Morbidity

  • Many serious human bites occur during fist fights between older children.1 Injury commonly occurs when a clenched fist strikes another individual's mouth and a tooth penetrates through the dermis of the knuckle into underlying connective tissue. Bacteria are inoculated into the metacarpophalangeal (MCP) joint. When the hand is extended, the contaminated tendon transfers the bacteria to a more proximal enclosed space. The patient may not immediately report this injury. Many times, the patient seeks medical care only after infection has developed.
  • Saliva has not been implicated as a risk for the transmission of human immunodeficiency virus (HIV).
  • A primary concern with all deep bite wounds is infection. In the complex anatomy of the hand, infection spreads along the course of the tendon sheaths. Patients with hand infections from bite wounds may require admission, intravenous antibiotics, and wound incision and drainage. Infection may cause a permanent disability of the hand.

Sex

  • The frequency of bite wounds is higher in males than in females.

Age

  • Older boys and adolescents have a higher incidence of closed-fist injuries because of their more aggressive behavior. In younger children, boys may collide with each other while engaging in sports. This may lead to a puncture wound of the forehead, scalp, or ear caused by a high-speed head-to-head contact, with penetration of the above tissues by a tooth. Puncture wounds to the head may be deceptively deep.



History

  • Eliciting a history of a human bite may be difficult at times. Adolescents may be evasive in their explanations regarding a wound over the MCP joint. Children may not know that they acquired a bite wound during a collision and may attribute a wound to blunt trauma. Recording the time of the injury is essential.
  • Often a patient is not present for medical care until signs of a wound infection are manifest. A wound over the MCP joint space should elicit a high index of suspicion of a human bite.
  • The potential diagnosis of a human bite should be entertained in children presenting with puncture wounds to the scalp or forehead.
  • The diagnosis of abuse should be considered in younger children especially if preverbal. Report bite marks with inconsistent explanations from caretakers.
  • Document the patient's immunological status.
  • Document the patient's tetanus vaccination status.

Physical

  • The physical examination should focus on depth of the wound, loss of tissue, presence of infection, and integrity of motor function.
  • Small abrasions and scrapes usually can be managed with soap and water.
  • Loss of tissue may be disfiguring. Areas with extensive destruction, such as the nose and ears, should be referred to a plastic surgeon.
  • Injuries to the MCP joint should be explored. Consider the possibility of fracture or a foreign body (tooth fragment). Referring patients with MCP joint injury to a hand surgeon for evaluation may be prudent.
  • Signs of infection in the hand warrant consultation with a hand surgeon, as well as intravenous antibiotics and admission.
  • Wounds to the scalp and forehead may be deceptively deep and can involve deeper structures.
  • Puncture wound have a higher risk of infection compared with lacerations. Lacerations tend to cause more tissue damage.

Causes

  • Alcohol use may be a contributing factor.
  • Abusive caretakers may bite younger children. Other injuries to the child, in addition to sexual abuse, should also be considered.
  • Disturbed family dynamics characterized by violent interactions may increase the risk of bite wounds.



Child Abuse & Neglect: Physical Abuse

Other Problems to be Considered

Cellulitis
Foreign body
Fracture
Insect bites



Lab Studies

  • Wound culture may be indicated. Although laboratory studies are not needed for a noninfected bite wound, an infected wound should be cultured.
  • A CBC count and an erythrocyte sedimentation rate (ESR) may aid evaluation of infections of more than a few days duration.
  • Some infectious disease experts also use C-reactive protein (CRP) studies to monitor the course of infection.

Imaging Studies

  • Radiography
    • Investigate the possibility of a foreign body or fracture following closed-fist bite wounds with radiographs of the hand.
    • The possibility of underlying osteomyelitis in an infection more than a few days duration mandates radiographic evaluation.
  • Bone scanning: This may be considered upon negative radiography findings to rule out osteomyelitis.

Procedures

  • Wound exploration is essential to evaluate the extent of damage to the affected area.
  • Wound cleansing is essential. Wounds should be copiously irrigated with isotonic sodium chloride solution.



Medical Care

  • Tetanus vaccine should be administered as needed.
  • Patients with infected wounds should be given antibiotics.
  • Patients with closed-fist infected wounds should be admitted for intravenous antibiotics and for possible incision and drainage.
  • Superficial wounds should be washed with soap and water.
  • Deeper wounds should be irrigated with a copious volume of normal saline (NS).

Surgical Care

  • Facial lacerations should be lavaged with isotonic sodium chloride solution and repaired primarily. Puncture wounds on the scalp or forehead should be closed secondarily as needed.
  • Potentially disfiguring facial lacerations, especially those to the nose and ears, should be repaired by a plastic surgeon.
  • Lacerations extending into the ear cartilage are at high risk for infection.

Consultations

  • Human bite wounds involving the nose or ears often require plastic surgery or ear, nose, and throat (ENT) consultation.
  • Bite wounds to the face associated with tissue loss should have a plastic surgery consultation.
  • Closed-fist injuries often require consultation with a hand surgeon.
  • Consultation with an infectious disease specialist may also be useful.



Infection is the most feared complication of human bites. Studies have demonstrated that bite infections are polymicrobial, with an average of 5 microorganisms cultured per wound. Antibiotic coverage for Staphylococcus species and anaerobes is usually necessary. Amoxicillin and clavulanate is used most commonly. Penicillin-allergic patients may be treated with a combination of trimethoprim/sulfamethoxazole and clindamycin. Patients who tolerate cephalosporin may also be treated with ceftriaxone. Prophylaxis may also be provided with erythromycin or a tetracycline. A 3- to 7-day course of antibiotic commonly is used for prophylaxis.

Drug Category: Antibiotic agents

These agents are used for prophylaxis and for treatment of infection.

Drug NameAmoxicillin and clavulanate (Augmentin)
DescriptionCombination antibiotic containing amoxicillin with a beta-lactamase inhibitor, which extends the antibiotic spectrum. Overall, the spectrum of this antibiotic provides the best prophylaxis against potential pathogens.
In children, base dose on the amoxicillin content. Because of the different amoxicillin-clavulanic acid ratios in the 250-mg tablets (250/125) vs the 250-mg chewable tablets (250/62.5), do not use the 250 mg tablet until the child weighs >40 kg.
Adult Dose500-875 mg PO bid
Pediatric Dose<3 months: Use the 125 mg/5 mL suspension and administer 30 mg/kg/d PO divided bid
>3 months: If using the 200 mg/5 mL or 400 mg/5 mL suspension, administer 45 mg/kg/d PO q12h; if using the 125 mg/5 mL or 250 mg/5 mL suspension, administer 40 mg/kg/d PO q8h
>40 kg: Administer as in adults
ContraindicationsDocumented hypersensitivity to penicillins; prior Augmentin-induced hepatic dysfunction
InteractionsProbenecid inhibits renal excretion of amoxicillin; coadministration with warfarin or heparin increases risk of bleeding
PregnancyB - Fetal risk not confirmed in studies in humans but has been shown in some studies in animals
PrecautionsCaution in patients with liver dysfunction or cholestatic jaundice; pseudomembranous colitis has been associated with Augmentin use; common adverse effects include rash and gastrointestinal upset

Drug NameAmpicillin and sulbactam (Unasyn)
DescriptionSimilar in spectrum to Augmentin. Treatment of choice for infected human bites. Contains two-thirds ampicillin and one-third sulbactam. Pediatric doses based on the ampicillin component.
Adult Dose1.5 g (1 g ampicillin plus 0.5 g sulbactam) IV q6h
Pediatric Dose100-150 mg/kg/d (based on ampicillin component) IV divided q6h
ContraindicationsDocumented hypersensitivity
InteractionsProbenecid inhibits renal elimination; allopurinol decreases ampicillin effects and has additive effects on ampicillin rash; may decrease effects of PO contraceptives
PregnancyB - Fetal risk not confirmed in studies in humans but has been shown in some studies in animals
PrecautionsMay cause pseudomembranous colitis; appearance of rash should be evaluated carefully to differentiate a nonallergic ampicillin rash from a hypersensitivity reaction; adjust dose in renal insufficiency

Drug NameTrimethoprim and sulfamethoxazole (Bactrim, Septra)
DescriptionUsed in combination with clindamycin for prophylaxis or treatment in patients who are allergic to penicillin. Inhibits bacterial synthesis of dihydrofolic acid by competing with para-aminobenzoic acid. TMP blocks the production of tetrahydrofolic acid by inhibiting the enzyme dihydrofolate reductase; thus, this combination blocks 2 consecutive steps in the bacterial biosynthesis of essential nucleic acids and proteins. In vitro, bacterial resistance develops more slowly with this combination than with either drug alone.
Adult Dose1 double-strength tab (160 mg TMP/800 mg SMZ) PO q12h
Pediatric Dose<2 months: Contraindicated
>2 months: 5-10 mg/kg/d (based on TMP component) PO divided q12h
ContraindicationsDocumented hypersensitivity; megaloblastic anemia caused by folate deficiency; age <2 mo
InteractionsMay increase PT of warfarin; monitor coagulation tests and adjust dosage as required; coadministration with dapsone may increase blood levels of both drugs; coadministration of diuretics increases incidence of thrombocytopenia purpura in elderly patients; phenytoin levels may increase with coadministration; may potentiate effects of methotrexate in bone marrow depression; hypoglycemic response to sulfonylureas may increase with coadministration; may increase levels of zidovudine
PregnancyC - Fetal risk revealed in studies in animals but not established or not studied in humans; may use if benefits outweigh risk to fetus
PrecautionsDiscontinue at first appearance of rash or sign of adverse reaction; obtain CBC counts frequently; discontinue therapy if significant hematologic changes occur; goiter, diuresis, and hypoglycemia may occur with sulfonamides; prolonged IV infusions or high doses may cause bone marrow depression (if signs occur, give 5-15 mg/d leucovorin); caution in folate deficiency (eg, chronic alcoholism, elderly persons, patients receiving anticonvulsant therapy, malabsorption syndrome); hemolysis may occur in G-6-PD deficiency; patients with AIDS may not tolerate or respond to TMP-SMZ; caution in renal or hepatic impairment (perform urinalyses and renal function tests during therapy); give fluids to prevent crystalluria and stone formation

Drug NameClindamycin (Cleocin)
DescriptionUsed for prophylaxis or treatment of the human bites in combination with TMP-SMX. Inhibits bacterial protein synthesis by its action at the bacterial ribosome. The antibiotic binds preferentially to the 50S ribosomal subunit and affects the process of peptide chain initiation.
Adult Dose150-450 mg PO q6-8h
1200-1800 mg IV divided bid/qid
Pediatric Dose10-30 mg/kg/d PO divided tid/qid
25-40 mg/kg/d IV divided q6-8h
ContraindicationsDocumented hypersensitivity; regional enteritis, ulcerative colitis, hepatic impairment, antibiotic-associated colitis
InteractionsIncreases duration of neuromuscular blockade induced by tubocurarine and pancuronium; erythromycin may antagonize effects of clindamycin; antidiarrheals may delay absorption of clindamycin
PregnancyB - Fetal risk not confirmed in studies in humans but has been shown in some studies in animals
PrecautionsAdjust dose in severe hepatic dysfunction; no adjustment necessary in renal insufficiency; associated with severe and possibly fatal colitis by allowing overgrowth of Clostridium difficile

Drug NameErythromycin (E.E.S., E-Mycin, Eryc, Erythrocin)
DescriptionUsed for prophylaxis in penicillin-allergic patients. Macrolide antibiotic with a large spectrum of activity. Binds to the 50S ribosomal subunit of bacteria, which inhibits protein synthesis.
Adult Dose250-500 mg (base, stearate, or estolate) PO qid or 400-800 mg (ethylsuccinate) PO qid
Pediatric Dose30-50 mg/kg/d (base and ethylsuccinate) PO divided q6-8h
ContraindicationsDocumented hypersensitivity; hepatic impairment
InteractionsCYP 3A4 inhibitor, erythromycin decreases clearance of terfenadine, cisapride, and astemizole, which may result in serious cardiac arrhythmias; decreases clearance of cyclosporine, midazolam, phenytoin, triazolam theophylline, and carbamazepine; may potentiate anticoagulant effect of warfarin
PregnancyB - Fetal risk not confirmed in studies in humans but has been shown in some studies in animals
PrecautionsCaution in liver disease; estolate formulation may cause cholestatic jaundice; GI adverse effects are common (give doses pc); discontinue use if nausea, vomiting, malaise, abdominal colic, or fever occur



Further Inpatient Care

  • The appropriate surgical subspecialties should be involved in the treatment of patients admitted to the hospital. Decisions to incise, drain, and explore tissue should be made after surgical consultation.
  • Consider bone scanning, despite normal radiograph findings, if osteomyelitis is suspected.
  • Appropriate dressings should be applied to bite wounds. Elevation of the affected extremity may be helpful.
  • Pain should be treated with appropriate analgesics.

Further Outpatient Care

  • Patients with significant closed-fist injuries without infection should be referred to a hand surgeon for reevaluation in 1-2 days.
  • Wound checks on closed facial bites should be scheduled.
  • Superficial bites need no follow-up.

Complications

  • A primary concern with all deep bite wounds is infection.
  • Most serious complications occur with human bites to the hand.

Patient Education



Medical/Legal Pitfalls

  • Any initial disability should be documented. Failure to suspect and treat a bite wound may result in or exacerbate long-term disability.
  • Failure to consider the possibility of an oral origin for puncture wounds to the head may lead to lack of treatment, inappropriate closure, and subsequent infection.
  • Bite wounds may have abusive origin in younger children. Failure to report suspected abuse may allow a child to be returned to an abusive environment.
  • Do not fail to consider bite wounds when evaluating injuries to the MCP area.
  • Failure to obtain radiographs of MCP wounds may result in undiagnosed (open) fractures and a possible sequela of osteomyelitis.
  • Glue should not be used on any bite wound.



  1. Leung AK, Robson WL. Human bites in children. Pediatric Emergency Care. 1992;8(5):255-257. [Medline].
  2. Baker MD, Moore SE. Human bites in children. A six-year experience. Am J Dis Child. Dec 1987;141(12):1285-90. [Medline].
  3. CID. Report of the committee on infectious diseases. In: Red Book. 24th ed. American Academy of Pediatrics; 1997:122-6.
  4. Lindsey D, Christopher M, Hollenbach J, et al. Natural course of the human bite wound: Incidence of infection and complications in 434 bites and 803 lacerations in the same group of patients. J Trauma. 1987;27:45-48. [Medline].
  5. Schweich P, Fleisher G. Human bites in children. Pediatr Emerg Care. Jun 1985;1(2):51-3. [Medline].

Human Bites excerpt

Article Last Updated: Dec 20, 2007